Navigation Links
DARA in Medical News

Sports Icons Troy Aikman, Clyde Drexler, Mike Piazza, Ivan Lendl and Dara Torres are Among the Elite Named 2009 'Great Sports Legends'

NEW YORK, Aug. 3 /PRNewswire/ -- Sports icons and philanthropy champions will be spotlighted when they gather at the 24 (th) Annual Great Sports Legends Dinner on Tuesday, October 6 , at New York's Waldorf=Astoria Hotel in the famed Grand Ballroom. Bob Costas will host the pro...

Swimmer Dara Torres Sports a White Upper Lip to Praise Milk as Her Post-Exercise Fitness Drink

Medal-Winning Mom 'Laps' Up Lowfat Milk to Help Keep Her Muscles and Bones in Top Shape WASHINGTON, April 8 /PRNewswire/ -- With summer on the horizon, millions of women have their sights on shedding bulky sweaters for swimsuits. Yet, award-winning swimmer and mom Dara Torres, 41, knows ther...

AAHSA Expert To Speak To Help Committee Briefing on Health Care Reform and Long-Term Services and Support

... Harkin to Host Event With Olympic Swimmer dara Torres WASHINGTON, June 7 /PRNewswire...or individuals with disabilities. Also speaking is dara Torres, a 10-time Olympic medalist in swimming, wh...rida. WHO: Senator Tom Harkin (D-IA) dara Torres, 10-time Olympic medalist, and long-term s...

Milkshakes are medicine for anorexic teens in family-based outpatient therapy

...egain the weight on his or her own. Nutritional rehabilitation gives the brain the nutrition it needs to re-establish healthy eating habits," says Dr. dara Bellace, a clinical psychologist at NewYork-Presbyterian Hospital/Westchester Division and an instructor of psychology in psychiatry at Weill Cornell ...

Seaweed and fireflies brew may guide stem cell treatment for peripheral artery disease

...isease conventional treatment is not feasible, researchers say. Among the technical hurdles to improving blood flow in such patients, according to dara L. Kraitchman, V.M.D., Ph.D., associate professor of radiology at Johns Hopkins, is a means of telling doctors whether injected stem cells are staying...

'Seeing' Stem Cells Helps in Fight Against Peripheral Arterial Disease

...em cell treatments for PAD, we need suitable noninvasive methods to track the fate of stem cells clearly inside the body," said veterinary radiologist dara L. Kraitchman, V.M.D., Ph.D., an associate professor at Johns Hopkins School of Medicine . Transplanting stem cells derived from bone marrow (not emb...

U-M Health Minute: Today's Top Health Issues and Medical Research

...ly represent the views of the Department of Veterans Affairs. Authors: In addition to Valenstein, authors of the paper were Hyungjin Myra Kim, dara Ganoczy, John F. McCarthy, Kara Zivin, Karen L. Austin, Katherine Hoggatt, Daniel Eisenberg, John D. Piette and Frederic C. Blow, all with affiliation...

Duane Reade Goes Pink to Support 2008 Komen New York City Race for the Cure(R)

...14th, New Yorkers will receive their purchases in the limited edition bags. "We are very thankful to have the generous support of Duane Reade," said dara P. Richardson-Heron, MD, CEO of Komen Greater New York City. "In 2008, more than 170,000 people will be diagnosed with breast cancer and 40,000 will d...

Rochester Medical Marketing VP Retires

...irstCall/ -- Rochester Medical Corporation (Nasdaq: ROCM ) today announced dara Lynn Horner's retirement from the position of Vice President -- Marketing. ... a fine contributor, but Rochester Medical's loss will be the world's gain. dara Lynn will be very supportive of all our efforts through the transition and ...

DARA Announces Surgi-Vision Agreement with Boston Scientific Corporation

... RALEIGH, N.C., April 16 /PRNewswire-FirstCall/ -- dara BioSciences(TM) (Nasdaq: dara ) announced today that Surgi-Vision, Inc., a privately held company of which dara Biosciences owns approximately 9.8% of the outstan...
DARA in Medical Technology

Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540

PRINCETON, N.J., April 15 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq: PCOP ), an innovator in the discovery and development of novel small molecule therapeutics, announced today that results from the company's Phase 2a clinical trial evaluating PS433540, its first-in-class Dual Acting Rec...

Pharmacopeia Announces Positive Results from Initial DARA Clinical Trial

PS433540 Shown to Be Well Tolerated and Potentially Suited for Once Daily Administration PRINCETON, N.J., April 10, 2007 /PRNewswire-FirstCall/ -- Pharmacopeia , an innovator in the discovery and development of novel small molecule therapeutics, today announced positive results from the initial Ph...

Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients

...ents include, but are not limited to, statements about the results of Pharmacopeia's Phase 2a clinical study of PS433540, a product candidate from its dara program, Pharmacopeia's plans to develop PS433540, Pharmacopeia's other Phase 2 and Phase 1 clinical studies with respect to PS433540, including timin...

Pharmacopeia Initiates Second Phase 2 Hypertension Study with PS433540 (DARA)

... Phase 2b Trial to Examine Safety and Efficacy of dara versus Active Control PRINCETON, N.J., March 3 /...433540 with irbesartan. "We are pleased with the dara program's rapid progress. This is our second Phase... to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinic...

Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA)

...ensive patients, we are pleased to have the opportunity to demonstrate that dara can effectively lower blood pressure in this patient population." Results...ans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect t...

Pharmacopeia Nominates Novel Chemokine Receptor Antagonist for Development

... Company Also Provides Update on dara Program's Ongoing Phase 2a Hypertension Study P...ram, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect t...

Pharmacopeia to Present at BIO CEO & Investor Conference 2008

...atements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...

Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)

... compounds and its receipt of milestones and royalties from the collaborations, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...

Pharmacopeia Announces Third Quarter 2007 Financial Results

...macopeia Advances and Expands Internal Pipeline as dara Program Enters Phase 2 Clinical Development ...540, an unpartnered product candidate from its dara program, that is both an angiotensin receptor bloc... to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinic...

Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate

...atements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 1 and Phase 2 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...
DARA in Biological News

'Seeing' stem cells helps in fight against peripheral arterial disease

...em cell treatments for PAD, we need suitable noninvasive methods to track the fate of stem cells clearly inside the body," said veterinary radiologist dara L. Kraitchman, V.M.D., Ph.D., an associate professor at Johns Hopkins School of Medicine. Transplanting stem cells derived from bone marrow (not embry...

Magnetic probe successfully tracks implanted cells in cancer patients

...he Netherlands. "The cells can't get from the fat into the lymph nodes by themselves, so injecting them properly is very important." Bulte says he, dara Kraitchman, Ph.D., D.V.M., and colleagues at Hopkins are already testing magnetically labeled stem cells with MRI-compatible injection systems to allo...
DARA in Biological Technology

RHEI Pharmaceuticals Appoints Dr. Geert Cauwenbergh as Chief Executive Officer

...h was also previously with the R&D organization of the Janssen Research Foundation in Belgium. Dr. Cauwenbergh currently serves as a Board member of dara Biosciences, Upstream Biosciences as well as Ablynx NV, and is a member of the Board of Trustees, and Vice Chairman of Bio New Jersey. Since 2004, Dr....

Pharmacopeia Advances Strategic Plan to Focus Resources on Development and Later-Stage Discovery Programs

...atements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...

Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc.

...atements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...

Pharmacopeia to Present at the 15TH Annual Future Leaders in the Biotech Industry Conference

...atements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...

Pharmacopeia to Receive $5 Million Payment from GlaxoSmithKline

... compounds and its receipt of milestones and royalties from the collaborations, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...

Pharmacopeia to Present at the Cowen and Company 28th Annual Health Care Conference

...atements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...

Pharmacopeia Announces Management Team Changes

...atements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...

DARA BioSciences, Inc. Announces Appointment of New Director to Board

... RALEIGH, N.C., Feb. 27 /PRNewswire-FirstCall/ -- dara BioSciences(TM) (Nasdaq: dara ) announced today the appointment of Haywood D. Co... of seven other publicly-traded companies. About dara BioSciences, Inc. ...

DARA BioSciences to Present at the ROTH Growth Stock Conference

... RALEIGH, N.C., Feb. 4 /PRNewswire/ -- dara BioSciences, Inc. today announced that the Company...on will be available at the same location. About dara BioSciences, Inc. dara BioSciences(TM), Inc. ("DARA") is a Raleigh, North...

Pharmacopeia To Present at BMO Capital Markets' Seventh Annual Focus on Healthcare Conference

...atements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...
Other Tags
(Date:7/12/2014)... 12, 2014 The Passenger Information System ... 2013 to $20,341.36 million by 2019, at an expected ... 2019. , The public transport infrastructure in North America ... available in almost every corner of the region. The ... of public transport service providers are driving the North ...
(Date:7/12/2014)... The rise in the number of mobility devices ... architectures to suit the upsurge. Virtualization has become a ... storage technologies. The data traffic has increased by several ... has resulted in larger and more complex networks. These ... SDN market. , The North American (NA) region is ...
(Date:7/12/2014)... Thompson HealthDay Reporter SATURDAY, ... guarantee that a surgical technique used to grind up uterine ... risk of spreading cancer to other parts of a woman,s ... to the Food and Drug Administration also said that women ... -- should sign a written consent stating that they understand ...
(Date:7/12/2014)... 12, 2014 In this ... ‘cognitive assessment and training’ is defined as ... train, or enhance cognitive functions. These solutions ... in dementia screening, clinical trials, driver’s safety, ... self assessment, brain training, and employers’ assessment ...
(Date:7/12/2014)... The Security Analytics market is estimated to grow ... 2019, at an expected CAGR of 9.7% for the ... the increasing number of security breaches, continued line of ... in organizations are enormous. Vendors in the security analytics ... to develop better and more secure systems. , There ...
Breaking Medicine News(10 mins):Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 4Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 4Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 5Health News:FDA Advisers Weigh Risks of Procedure for Removal of Uterine Fibroids 2Health News:FDA Advisers Weigh Risks of Procedure for Removal of Uterine Fibroids 3Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 2Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 3Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 4Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 5Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 4
(Date:7/10/2014)... -- Fingerprint Cards, (FPC,s) new mobile touch sensor ... Chinese Top 5 smartphone OEM has selected FPC1021 for a ... October 2014.   FPC is proud to announce ... has a planned date for the start of mass production ... phone of 3 million units. The Chinese OEM wants to ...
(Date:7/10/2014)... Sweden , July 8, 2014 ... has won a new design win (DW). An Asian OEM ... date for mass production start in August 2014.   ... Asian smartphone OEM, which has a planned date for start ... an initial ramp order of SEK 5M, for delivery in ...
(Date:7/10/2014)... Ill. , July 9, 2014 ... (EHR), spurred in large part by meaningful use ... health care providers interact with laboratory information. Now, ... in the field of clinical informatics in order ... To address the educational needs of ...
Breaking Biology News(10 mins):FPC Wins DW for 1021 Touch Sensor for Flagship Smartphone from Chinese Top 5 Smartphone OEM 2FPC Wins DW and Initial Ramp Order for FPC1021 Touch Sensor for Flagship Smartphone from Asian OEM 2New Clinical Informatics Curriculum Prepares Future Pathologists 2New Clinical Informatics Curriculum Prepares Future Pathologists 3New Clinical Informatics Curriculum Prepares Future Pathologists 4
Other Contents